Abstract:OBJECTIVE:To study the outcomes of nerve defect repair with the tissue engineered nerve, which is composed of the complex of SCs, 30% ECM gel, bFGF-PLGA sustained release microspheres, PLGA microfilaments and permeable poly (D, L-lactic acid) (PDLLA) catheters.METHODS:SCs were cultured and purified from the sciatic nerves of 1-day-old neonatal SD rats. The 1st passage cells were compounded with bFGF-PLGA sustained release microspheres and ECM gel, and then were injected into permeable PDLLA catheters with PLGA microfilaments inside. In this way, the tissue engineered nerve was constructed. Sixty SD rats were included. The model of 15-mm sciatic nerve defects was made, and then the rats were randomly divided into 5 groups, with 12 rats in each. In group A, autograft was adopted. In group B, the blank PDLLA catheters with PBS inside were used. In group C, PDLLA catheters, with PLGA microfilaments and 30% ECM gel inside, were used. In group D, PDLLA catheters, with PLGA microfilaments, SCs and 30% ECM gel inside, were used. In group E, the tissue engineered nerve was applied. After the operation, observation was made for general conditions of the rats. The sciatic function index (SFI) analysis was performed at 12, 16, 20 and 24 weeks after the operation, respectively. Electrophysiological detection and histological observation were performed at 12 and 24 weeks after the operation, respectively.RESULTS:All rats survived to the end of the experiment. At 12 and 16 weeks after the operation, group E was significantly different from group B in SFI (P < 0.05). At 20 and 24 weeks after the operation, group E was significantly different from groups B and C in SFI (P < 0.05). At 12 weeks after the operation, electrophysiological detection showed nerve conduct velocity (NCV) of group E was bigger than that of groups B and C (P < 0.05), and compound amplitude (AMP) as well as action potential area (AREA) of group E were bigger than those of groups B, C and D (P < 0.05). At 24 weeks after the operation, NCV, AMP and AREA of group E were bigger than those of groups B and C (P < 0.05). At 12 weeks after the operation, histological observation showed the area of regenerated nerves and the number of myelinated fibers in group E were significantly differents from those in groups A, B and C (P < 0.05). The density and diameter of myelinated fibers in group E were smaller than those in group A (P < 0.05), but bigger than those in groups B, C and D (P < 0.05). At 24 weeks after the operation, the area of regenerative nerves in group E is bigger than those in group B (P < 0.05); the number of myelinated fibers in group E was significantly different from those in groups A, B, C (P < 0.05); and the density and diameter of myelinated fibers in group E were bigger than those in groups B and C (P < 0.05).CONCLUSION:The tissue engineered nerve with the complex of SCs, ECM gel, bFGF-PLGA sustained release microspheres, PLGA microfilaments and permeable PDLLA catheters promote nerve regeneration and has similar effect to autograft in repair of nerve defects.

Peripheral Nerve Repair: Monitoring by Using Gadofluorine M-Enhanced Mr Imaging with Chitosan Nerve Conduits with Cultured Mesenchymal Stem Cells in Rat Model of Neurotmesis

Enhanced Repair Effect Of Toll-Like Receptor 4 Activation On Neurotmesis: Assessment Using Mr Neurography

In vivo MRI monitoring nerve regeneration of acute peripheral nerve traction injury following mesenchymal stem cell transplantation.

Magnetic resonance imaging of enhanced nerve repair with mesenchymal stem cells combined with microenvironment immunomodulation in neurotmesis

Repair of Rat Sciatic Nerve Gap by a Silk Fibroin-Based Scaffold Added with Bone Marrow Mesenchymal Stem Cells.

[Construction and Evaluation of the Tissue Engineered Nerve of Bfgf-Plga Sustained Release Microspheres].

Repair of Rat Sciatic Nerve Defects by Using Allogeneic Bone Marrow Mononuclear Cells Combined with Chitosan/Silk Fibroin Scaffold

Peripheral nerve regeneration using carbon nanotubes enhanced chitosan/collagen composite nerve conduit

Repair of nerve defects with de-acetyl chitin nerve conduit perfused with mesenchymal stem cells

Long-term Outcome of the Repair of 50 Mm Long Median Nerve Defects in Rhesus Monkeys with Marrow Mesenchymal Stem Cells-Containing, Chitosan-Based Tissue Engineered Nerve Grafts

Incorporation of Chitosan Microspheres into Collagen-Chitosan Scaffolds for the Controlled Release of Nerve Growth Factor.

Exosomes from Human Gingiva-Derived Mesenchymal Stem Cells Combined with Biodegradable Chitin Conduits Promote Rat Sciatic Nerve Regeneration

A Magnetically Responsive Nanocomposite Scaffold Combined with Schwann Cells Promotes Sciatic Nerve Regeneration Upon Exposure to Magnetic Field

The delayed repair of sciatic nerve defects with tissue-engineered nerve grafts in rats.

Peripheral Nerve Regeneration through Hydrogel-Enriched Chitosan Conduits Containing Engineered Schwann Cells for Drug Delivery

Brain Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor-Transfected Bone Mesenchymal Stem Cells for the Repair of Periphery Nerve Injury

Improvement of Peripheral Nerve Regeneration by a Tissue-Engineered Nerve Filled with Ectomesenchymal Stem Cells

Repairing rat sciatic nerve injury by a nerve-growth-factor-loaded, chitosan-based nerve conduit.

Biomimetic chitosan scaffolds with long-term controlled release of nerve growth factor repairs 20-mm-long sciatic nerve defects in rats

[Tissue Engineered Nerve Based on Plasma Treatment and BMSCs].

Facilitation of Cell Cycle and Cellular Migration of Rat Schwann Cells by O-Carboxymethyl Chitosan to Support Peripheral Nerve Regeneration